Joshua Makower, M.D.

Who is Joshua Makower, M.D.?

Dr. Makower is the Founder Chief Executive Officer of ExploraMed II, Inc.,

a medical device incubator based on the west coast and is also a Venture Partner

with New Enterprise Associates.

Dr. Makower serves as a Consulting Associate Professor of Medicine at Stanford

University Medical School and is Director of Stanford’s Biodesign Innovation

Program.

Prior to this, he was Founder, Chairman and Chief Technical Officer of TransVascular,

Inc. a company focused on the development of a completely catheter-based coronary

bypass technology, which was acquired by Medtronic, Inc. in 2003, and Founder

and Chairman of EndoMatrix, Inc., a company focused on the development of a novel

therapy for incontinence and GI Reflux, which was acquired by C.R. Bard in 1997.

Up until 1995, Dr. Makower was Founder and Manager of Pfizer’s Strategic

Innovation Group, a group chartered to create new medical device technologies

and businesses for Pfizer’s medical devices businesses.

Dr. Makower holds over four dozen patents for various medical devices in the

fields of Cardiology, General Surgery, Drug Delivery and Urology. Dr. Makower

holds a Masters of Business Administration degree from Columbia University, a

Doctor of Medicine degree from the New York University School of Medicine, and

a Bachelor of Science degree in Mechanical Engineering from the Massachusetts

Institute of Technology.

Dr. Makower also serves as Chairman of the Board for Acclarent, Inc. - a venture

backed company focused on the treatment of ENT disorders, and NeoTract, Inc. – ExploraMed’s

most recent spin out, and on the Board of Directors for Intrinsic Therapeutics,

Inc. - a venture backed private company developing innovative spinal therapies,

and ReVance, Inc. – a venture backed private company developing new molecular

carriers to transport therapeutic substances across membranes